We did not find an effect of the IL1B-TGCT haplotype on CRC risk, which could be explained in part by the small sample size or the fact that this haplotype exhibits moderate transcriptional activity in vitro10, making it more suitable as a susceptibility marker of milder lesions that do not necessarily evolve to CRC. This evidence concerns the gene IL1B and colorectal carcinoma.